Cargando…

Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function

Dopamine is a key regulator of glucose metabolism in the central nervous system. However, dopamine is also present in the periphery and may have direct effects on insulin-sensitive tissues. Dopamine receptor 2 (D2R) agonist bromocriptine is a FDA-approved drug for type 2 diabetes. Herein, we explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavares, Gabriela, Martins, Fatima. O., Melo, Bernardete. F., Matafome, Paulo, Conde, Silvia. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458637/
https://www.ncbi.nlm.nih.gov/pubmed/34566639
http://dx.doi.org/10.3389/fphar.2021.713418
_version_ 1784571336123744256
author Tavares, Gabriela
Martins, Fatima. O.
Melo, Bernardete. F.
Matafome, Paulo
Conde, Silvia. V.
author_facet Tavares, Gabriela
Martins, Fatima. O.
Melo, Bernardete. F.
Matafome, Paulo
Conde, Silvia. V.
author_sort Tavares, Gabriela
collection PubMed
description Dopamine is a key regulator of glucose metabolism in the central nervous system. However, dopamine is also present in the periphery and may have direct effects on insulin-sensitive tissues. Dopamine receptor 2 (D2R) agonist bromocriptine is a FDA-approved drug for type 2 diabetes. Herein, we explored the role of peripheral dopamine and its receptors in regulating glucose uptake and metabolism on insulin-sensitive tissues. Peripheral dopamine effect in [3H]2-deoxyglucose uptake in insulin-sensitive tissues was tested in vivo in rats. Direct effects on [3H]2-deoxyglucose uptake, insulin receptor phosphorylation, and regulation of metabolic function were tested ex vivo in the liver, soleus muscle, and white and brown adipose tissues. Bromocriptine and the antagonists domperidone, D2R antagonist, and haloperidol, antagonist of both dopamine receptor 1 (D1R) and D2R, were used to disclose dopamine receptors’ involvement. Peripheral dopamine increases glucose uptake in vivo. Ex vivo, only dopamine increased glucose uptake in the soleus, while bromocriptine increased it in the liver; the effects were reverted by haloperidol and domperidone, respectively. In adipose tissue, domperidone reverted dopamine- and bromocriptine-mediated potentiation of insulin-induced glucose uptake, but in turn increased the insulin receptor, Akt, AMPK, HSL, ACC, and ACL, phosphorylation. In the soleus muscle, AMPK-phosphorylation increased with bromocriptine and dopamine whose effects were suppressed by domperidone and haloperidol. In conclusion, peripheral dopamine stimulates glucose uptake with its receptors being differentially involved in glucose uptake in insulin-sensitive tissues. Dopamine also has a role in lipid metabolism in white adipose tissue. Altogether, these results suggest that peripheral modulation of the dopaminergic system should be further evaluated as a putative therapeutic approach for metabolic disorders.
format Online
Article
Text
id pubmed-8458637
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84586372021-09-24 Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function Tavares, Gabriela Martins, Fatima. O. Melo, Bernardete. F. Matafome, Paulo Conde, Silvia. V. Front Pharmacol Pharmacology Dopamine is a key regulator of glucose metabolism in the central nervous system. However, dopamine is also present in the periphery and may have direct effects on insulin-sensitive tissues. Dopamine receptor 2 (D2R) agonist bromocriptine is a FDA-approved drug for type 2 diabetes. Herein, we explored the role of peripheral dopamine and its receptors in regulating glucose uptake and metabolism on insulin-sensitive tissues. Peripheral dopamine effect in [3H]2-deoxyglucose uptake in insulin-sensitive tissues was tested in vivo in rats. Direct effects on [3H]2-deoxyglucose uptake, insulin receptor phosphorylation, and regulation of metabolic function were tested ex vivo in the liver, soleus muscle, and white and brown adipose tissues. Bromocriptine and the antagonists domperidone, D2R antagonist, and haloperidol, antagonist of both dopamine receptor 1 (D1R) and D2R, were used to disclose dopamine receptors’ involvement. Peripheral dopamine increases glucose uptake in vivo. Ex vivo, only dopamine increased glucose uptake in the soleus, while bromocriptine increased it in the liver; the effects were reverted by haloperidol and domperidone, respectively. In adipose tissue, domperidone reverted dopamine- and bromocriptine-mediated potentiation of insulin-induced glucose uptake, but in turn increased the insulin receptor, Akt, AMPK, HSL, ACC, and ACL, phosphorylation. In the soleus muscle, AMPK-phosphorylation increased with bromocriptine and dopamine whose effects were suppressed by domperidone and haloperidol. In conclusion, peripheral dopamine stimulates glucose uptake with its receptors being differentially involved in glucose uptake in insulin-sensitive tissues. Dopamine also has a role in lipid metabolism in white adipose tissue. Altogether, these results suggest that peripheral modulation of the dopaminergic system should be further evaluated as a putative therapeutic approach for metabolic disorders. Frontiers Media S.A. 2021-09-09 /pmc/articles/PMC8458637/ /pubmed/34566639 http://dx.doi.org/10.3389/fphar.2021.713418 Text en Copyright © 2021 Tavares, Martins, Melo, Matafome and Conde. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Tavares, Gabriela
Martins, Fatima. O.
Melo, Bernardete. F.
Matafome, Paulo
Conde, Silvia. V.
Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function
title Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function
title_full Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function
title_fullStr Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function
title_full_unstemmed Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function
title_short Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function
title_sort peripheral dopamine directly acts on insulin-sensitive tissues to regulate insulin signaling and metabolic function
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458637/
https://www.ncbi.nlm.nih.gov/pubmed/34566639
http://dx.doi.org/10.3389/fphar.2021.713418
work_keys_str_mv AT tavaresgabriela peripheraldopaminedirectlyactsoninsulinsensitivetissuestoregulateinsulinsignalingandmetabolicfunction
AT martinsfatimao peripheraldopaminedirectlyactsoninsulinsensitivetissuestoregulateinsulinsignalingandmetabolicfunction
AT melobernardetef peripheraldopaminedirectlyactsoninsulinsensitivetissuestoregulateinsulinsignalingandmetabolicfunction
AT matafomepaulo peripheraldopaminedirectlyactsoninsulinsensitivetissuestoregulateinsulinsignalingandmetabolicfunction
AT condesilviav peripheraldopaminedirectlyactsoninsulinsensitivetissuestoregulateinsulinsignalingandmetabolicfunction